Moreno-Aspitia A - Search Results

1

Incidence of Late Relapses in Patients With HER2-Positive Breast Cancer Receiving Adjuvant Trastuzumab: Combined Analysis of NCCTG N9831 (Alliance) and NRG Oncology/NSABP B-31.

Chumsri S, Li Z, Serie DJ, Mashadi-Hossein A, Colon-Otero G, Song N, Pogue-Geile KL, Gavin PG, Paik S, Moreno-Aspitia A, Perez EA, Thompson EA. Chumsri S, et al. J Clin Oncol. 2019 Dec 10;37(35):3425-3435. doi: 10.1200/JCO.19.00443. Epub 2019 Oct 17. J Clin Oncol. 2019. PMID: 31622131 Free PMC article. Clinical Trial.

2

North Central Cancer Treatment Group N0531: Phase II Trial of weekly albumin-bound paclitaxel (ABI-007; Abraxane) in combination with gemcitabine in patients with metastatic breast cancer.

Moreno-Aspitia A, Perez EA. Moreno-Aspitia A, et al. Clin Breast Cancer. 2005 Oct;6(4):361-4. doi: 10.3816/CBC.2005.n.042. Clin Breast Cancer. 2005. PMID: 16277889 No abstract available.

3

Nanoparticle albumin-bound paclitaxel (ABI-007): a newer taxane alternative in breast cancer.

Moreno-Aspitia A, Perez EA. Moreno-Aspitia A, et al. Future Oncol. 2005 Dec;1(6):755-62. doi: 10.2217/14796694.1.6.755. Future Oncol. 2005. PMID: 16556053 Review.

4

Thalidomide therapy in adult patients with myelodysplastic syndrome. A North Central Cancer Treatment Group phase II trial.

Moreno-Aspitia A, Colon-Otero G, Hoering A, Tefferi A, Niedringhaus RD, Vukov A, Li CY, Menke DM, Geyer SM, Alberts SR; North Central Cancer Treatment Group. Moreno-Aspitia A, et al. Cancer. 2006 Aug 15;107(4):767-72. doi: 10.1002/cncr.22047. Cancer. 2006. PMID: 16826578 Free article. Clinical Trial.

5

Issues and controversies in the treatment of HER2 positive metastatic breast cancer.

Amar S, Moreno-Aspitia A, Perez EA. Amar S, et al. Breast Cancer Res Treat. 2008 May;109(1):1-7. doi: 10.1007/s10549-007-9636-2. Epub 2007 Jul 26. Breast Cancer Res Treat. 2008. PMID: 17653858 Review.

6

Platelet count is a sensitive predictor of autologous peripheral blood progenitor cell collection yield in previously treated plasma cell disease patients.

Zubair AC, Grant R, Wu W, Tun H, Rivera C, Moreno-Aspitia A, Joyce M, Roy V, Colon-Otero G, Solberg LA. Zubair AC, et al. Transfusion. 2008 Jun;48(6):1106-14. doi: 10.1111/j.1537-2995.2008.01651.x. Epub 2008 Feb 25. Transfusion. 2008. PMID: 18315528 Free PMC article.

7

Phase II trial of sorafenib in patients with metastatic breast cancer previously exposed to anthracyclines or taxanes: North Central Cancer Treatment Group and Mayo Clinic Trial N0336.

Moreno-Aspitia A, Morton RF, Hillman DW, Lingle WL, Rowland KM Jr, Wiesenfeld M, Flynn PJ, Fitch TR, Perez EA. Moreno-Aspitia A, et al. J Clin Oncol. 2009 Jan 1;27(1):11-5. doi: 10.1200/JCO.2007.15.5242. Epub 2008 Dec 1. J Clin Oncol. 2009. PMID: 19047293 Free PMC article. Clinical Trial.

8

Treatment options for breast cancer resistant to anthracycline and taxane.

Moreno-Aspitia A, Perez EA. Moreno-Aspitia A, et al. Mayo Clin Proc. 2009 Jun;84(6):533-45. doi: 10.4065/84.6.533. Mayo Clin Proc. 2009. PMID: 19483170 Free PMC article. Review.

9

Anthracycline- and/or taxane-resistant breast cancer: results of a literature review to determine the clinical challenges and current treatment trends.

Moreno-Aspitia A, Perez EA. Moreno-Aspitia A, et al. Clin Ther. 2009 Aug;31(8):1619-40. doi: 10.1016/j.clinthera.2009.08.005. Clin Ther. 2009. PMID: 19808124 Review.

10

Adjuvant therapy of triple negative breast cancer.

Perez EA, Moreno-Aspitia A, Aubrey Thompson E, Andorfer CA. Perez EA, et al. Breast Cancer Res Treat. 2010 Apr;120(2):285-91. doi: 10.1007/s10549-010-0736-z. Epub 2010 Jan 22. Breast Cancer Res Treat. 2010. PMID: 20094772 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

87 results

Search Page

Filters